CVS takes a hit after a rough earnings update, but its health insurance arm keeps adding members and bringing in more revenue, helped by government-backed plans. The big question is whether store closures, cost cuts, and folding in recent healthcare deals can tame rising medical costs and restore confidence.Read more

AbbVie leans on newer medicines in immunology and brain health to replace sales lost as its older blockbuster faces growing competition. The big question is whether new launches, pipeline bets, and overseas growth can keep results steady while pricing pressure and a heavy reliance on a few drugs raise the stakes.Read more